Status:
COMPLETED
Changes in Liver Function After Stereotactic Body Radiation Therapy Measured by PET/CT
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
Danish Cancer Society
Conditions:
Hepatocellular Carcinoma
Cholangiocarcinoma
Eligibility:
All Genders
18-85 years
Brief Summary
Patients treated with stereotactic radiotherapy for liver tumors undergo PET/CT using the galactose analogue 18-F-deoxy-galactose (FDGal) before and after radiotherapy. This technique provides volumet...
Eligibility Criteria
Inclusion
- liver tumor
- referred for stereotactic radiation therapy
- age \> 18 years
Exclusion
- Impaired kidney function
- Pregnancy
Key Trial Info
Start Date :
June 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2016
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT01213758
Start Date
June 1 2010
End Date
April 1 2016
Last Update
October 30 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital
Aarhus C, Denmark, 8000